2006Xinxiang yixueyuan xuebaoRequires access

The change of periphral CD4~+ and CD25~+ regulatory T cells in patients with asthma

Xiaosong Shi

Open publisher page 0 citations

Abstract

Objective To investigate the role of CD4~+ and CD25~+ regulatory T cells in the pathogenesis of asthma for the purpose of giving new approach of treatment.Methods The monouclear cells(PBMC) were isolated from peripheral blood of asthmatic patients and control subjects,and the phenotype and percentage of CD4~+ and CD25~+ regulatory T cells was detemined by Flow cytometry.Results The percentage of CD4~+and CD25~+ regulatory T cells in total T cells has significantly difference between control group(8.5±2.6)% and asthmatic patients(4.2±1.5)%(P0.05).The CTLA-4 and CD69 molecules in CD4~+ and CD25~+ regulatory T cells were no significantly difference between control group and asthmatic patients(P0.05).Conclusion The CD4~+and CD25~+ regulatory T leets involved in the pathogenesis of asthma in human.

About this research paper

What this paper is about

Objective To investigate the role of CD4~+ and CD25~+ regulatory T cells in the pathogenesis of asthma for the purpose of giving new approach of treatment.Methods The monouclear cells(PBMC) were isolated from peripheral blood of asthmatic patients and control subjects,and the phenotype and percentage of CD4~+ and CD25~+ regulatory T cells was detemined by Flow cytometry.Results The percentage of CD4~+and CD25~+ regulatory T cells in total T cells has significantly difference between control group(8.5±2.6)% and asthmatic patients(4.2±1.5)%(P0.05).The CTLA-4 and CD69 molecules in CD4~+ and CD25~+ regulatory T cells were no significantly difference between control group and asthmatic patients(P0.05).Conclusion The CD4~+and CD25~+ regulatory T leets involved in the pathogenesis of asthma in human.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the role of CD4~+ and CD25~+ regulatory T cells in the pathogenesis of asthma for the purpose of giving new approach of treatment.Methods The monouclear cells(PBMC) were isolated from peripheral blood of asthmatic patients and control subjects,and the phenotype and percentage of CD4~+ and CD25~+ regulatory T cells was detemined by Flow cytometry.Results The percentage of CD4~+and CD25~+ regulatory T cells in total T cells has significantly difference between control group(8.5±2.6)% and asthmatic patients(4.2±1.5)%(P0.05).The CTLA-4 and CD69 molecules in CD4~+ and CD25~+ regulatory T cells were no significantly difference between control group and asthmatic patients(P0.05).Conclusion The CD4~+and CD25~+ regulatory T leets involved in the pathogenesis of asthma in human.

Key concepts: IL-2 receptor, Pathogenesis, Flow cytometry, Peripheral blood mononuclear cell, Asthma, Immunology, Medicine, Biology

Related papers

Back to paper searchBrowse research topicsOriginal source
The change of periphral CD4~+ and CD25~+ regulatory T cells in patients with asthma — Research Paper | ScholarLens